Syngene International Limited
$9.62
24H
Market Cap
Volume
Supply
Price Chart
About Syngene International Limited - SYNGENE.BO
Syngene International Limited is an India-based contract research organization that offers a range of integrated scientific services to pharmaceutical, biotechnology, and healthcare companies globally, including drug discovery, development, and manufacturing services. It was established in 1994 and operates as a subsidiary of Biocon Limited, one of India's largest biopharmaceutical companies.
What are Syngene International Limited's core values and mission statement?
Syngene International Limited, a contract research organization, has a mission to deliver outstanding scientific services and solutions, while their core values revolve around customer focus, quality, innovation, integrity, and collaboration to support their clients' success in the field of integrated scientific research and development.
Who founded Syngene International Limited and when?
Syngene International Limited was founded by Kiran Mazumdar-Shaw in 1993.
Who leads Syngene International Limited?
Syngene International Limited is led by a CEO, who oversees the operations and strategic direction of the company. The specific individual in that role can change and should be verified with the most current resources available.
Where is Syngene International Limited located, and what is its base country?
Syngene International Limited is headquartered in Bangalore, India.
On which exchanges is Syngene International Limited traded?
Syngene International Limited is listed and traded on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Historical data
Syngene International Limited (SYNGENE) Price Live Data
The live price of Syngene International Limited (SYNGENE) is $9.62, with a trading volume of 55,588 in the last 24 hours. Wrapstocks updates the SYNGENE price in real-time. Syngene International Limited is up 1.92% in the last 24 hours. The company has a live market cap of $3,854,169,900.32 and a supply of 400,808,018 SYNGENE stocks.
Syngene International Limited (SYNGENE) is traded on Bombay Stock Exchange, and currently, the market is open; trading will be paused in 48 minutes.